Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-04

Clinical Trial Update: Evaluation of the Safety Use of the InsuPatch Device in Daily Life Conditions [Phase 4]

View source ↗

Summary

Phase 4 safety evaluation of the InsuPatch device in daily life conditions for individuals with Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • InsuPatch

Snippet

Sponsor: Insuline Medical Ltd. | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED